Pyxis Oncology Coverage Assumed by Jefferies at Buy

Pyxis Oncology Coverage Assumed by Jefferies at Buy

Dow JonesMay 7 20:17

Jefferies Investment Bank: Assuming Pyxis Oncology (PYXS.US) rating, adjusted from buy to buy rating, target price is $10.00.

Jefferies Investment Bank: Assuming Pyxis Oncology (PYXS.US) rating, adjusted from buy to buy rating, target price is $10.00.

Zhitong FinanceMay 7 20:10

Jefferies Assumes Pyxis Oncology at Buy, Announces Price Target of $10

Jefferies analyst Farzin Haque assumes Pyxis Oncology (NASDAQ:PYXS) with a Buy rating and announces Price Target of $10.

BenzingaMay 7 20:07

HROW, HCAT and EGRX Are Among After Hour Movers

Seeking AlphaApr 13 05:05

Buy Rating Affirmed for Pyxis Oncology as PYX-201 Showcases Promising Preclinical Data and Broad Therapeutic Potential

Analyst Swayampakula Ramakanth of H.C. Wainwright maintained a Buy rating on Pyxis Oncology (PYXS – Research Report), retaining the price target of $7.00.

TipRanksApr 10 18:27

HC Wainwright & Co. : Pyxis Oncology (PYXS.US) rating was reaffirmed and adjusted from buy to buy, with a target price of $7.00.

HC Wainwright & Co. : Pyxis Oncology (PYXS.US) rating was reaffirmed and adjusted from buy to buy, with a target price of $7.00.

Zhitong FinanceApr 10 18:11